<SEC-DOCUMENT>0001683168-17-000541-index.html : 20170313
<SEC-HEADER>0001683168-17-000541.hdr.sgml : 20170313
<ACCEPTANCE-DATETIME>20170313080245
ACCESSION NUMBER:		0001683168-17-000541
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20170131
FILED AS OF DATE:		20170313
DATE AS OF CHANGE:		20170313

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PharmaCyte Biotech, Inc.
		CENTRAL INDEX KEY:			0001157075
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				621772151
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0430

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	333-68008
		FILM NUMBER:		17683975

	BUSINESS ADDRESS:	
		STREET 1:		23046 AVENIDA DE LA CARLOTA, SUITE 600
		CITY:			LAGUNA HILLS
		STATE:			CA
		ZIP:			92653
		BUSINESS PHONE:		(917) 595.2850

	MAIL ADDRESS:	
		STREET 1:		23046 AVENIDA DE LA CARLOTA, SUITE 600
		CITY:			LAGUNA HILLS
		STATE:			CA
		ZIP:			92653

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUVILEX, INC.
		DATE OF NAME CHANGE:	20090324

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EFOODSAFETY COM INC
		DATE OF NAME CHANGE:	20010808
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>pharmacyte_10q-013117.htm
<DESCRIPTION>FORM 10-Q
<TEXT>
Document 1 - file: pharmacyte_10q-013117.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>pharmacyte_10q-ex1001.htm
<DESCRIPTION>EXECUTIVE COMPENSATION AGREEMENT - KENNETH L. WAGGONER
<TEXT>
Document 2 - file: pharmacyte_10q-ex1001.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>pharmacyte_10q-ex1002.htm
<DESCRIPTION>EXECUTIVE COMPENSATION AGREEMENT - CARLOS A. TRUJILLO
<TEXT>
Document 3 - file: pharmacyte_10q-ex1002.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>pharmacyte_10q-ex1003.htm
<DESCRIPTION>EXECUTIVE COMPENSATION AGREEMENT - GERALD W. CRABTREE
<TEXT>
Document 4 - file: pharmacyte_10q-ex1003.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>pharmacyte_10q-ex1004.htm
<DESCRIPTION>FOURTH STOCK OPTION AGREEMENT - GERALD W. CRABTREE
<TEXT>
Document 5 - file: pharmacyte_10q-ex1004.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>6
<FILENAME>pharmacyte_10q-ex1005.htm
<DESCRIPTION>THIRD STOCK OPTION AGREEMENT - CARLOS A. TRUJILLO
<TEXT>
Document 6 - file: pharmacyte_10q-ex1005.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>7
<FILENAME>pharmacyte_10q-ex1006.htm
<DESCRIPTION>FOURTH STOCK OPTION AGREEMENT - KENNETH L. WAGGONER
<TEXT>
Document 7 - file: pharmacyte_10q-ex1006.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.7
<SEQUENCE>8
<FILENAME>pharmacyte_10q-ex1007.htm
<DESCRIPTION>AMENDMENT #1 TO DIRECTOR OFFER LETTER
<TEXT>
Document 8 - file: pharmacyte_10q-ex1007.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>9
<FILENAME>pharmacyte_10q-ex3101.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
Document 9 - file: pharmacyte_10q-ex3101.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>10
<FILENAME>pharmacyte_10q-ex3102.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
Document 10 - file: pharmacyte_10q-ex3102.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>11
<FILENAME>pharmacyte_10q-ex3201.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
Document 11 - file: pharmacyte_10q-ex3201.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>12
<FILENAME>pharmacyte_10q-ex3202.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
Document 12 - file: pharmacyte_10q-ex3202.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>pharmacyte_logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 13 - file: pharmacyte_logo.jpg

</DOCUMENT>
</SEC-DOCUMENT>